Concord Biotech Ltd vs Denis Chem Lab Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 12, 2026

Key Highlights

The Latest Trading Price of Concord Biotech Ltd is ₹ 1351 as of 12 Jun 15:30 . The P/E Ratio of Concord Biotech Ltd changed from 51.7 on March 2024 to 47.2 on March 2025 . This represents a CAGR of -4.45% over 2 yearsThe P/E Ratio of Denis Chem Lab Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Concord Biotech Ltd changed from ₹ 15922 crore on March 2024 to ₹ 17537 crore on March 2025 . This represents a CAGR of 4.95% over 2 yearsThe Market Cap of Denis Chem Lab Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Concord Biotech Ltd for the Mar '26 is ₹ 341.43 crore as compare to the Dec '25 revenue of ₹ 287.74 crore. This represent the growth of 18.66% The revenue of Denis Chem Lab Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Concord Biotech Ltd for the Mar '26 is ₹ 133.7 crore as compare to the Dec '25 ebitda of ₹ 104.98 crore. This represent the growth of 27.36% The ebitda of Denis Chem Lab Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Concord Biotech Ltd changed from ₹ 59.59 crore to ₹ 88.47 crore over 8 quarters. This represents a CAGR of 21.85% The net profit of Denis Chem Lab Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Concord Biotech Ltd changed from 2.73 % on March 2022 to 24.54 % on March 2025 . This represents a CAGR of 73.15% over 4 yearsThe Dividend Payout of Denis Chem Lab Ltd changed from 46.06 % on March 2021 to 25.77 % on March 2025 . This represents a CAGR of -10.97% over 5 years .

About Concord Biotech Ltd

Concord Biotech Limited was originally incorporated as Servomed Pharmaceuticals Private Limited' at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of Companies.
Thereafter, name of the Company was changed to Concord Biotech Limited' dated February 16, 2001, which became a Public Company and a fresh Certificate of Incorporation dated November 7, 2001 was issued by the RoC. The Company is an India-based bio pharma and one of the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in supplying to over 70 countries including regulated markets, such as the United States, Europe and Japan, and India.
Presently, it is engaged in research and development, manufacturing, marketing and selling of pharmaceutical products.

About Denis Chem Lab Ltd

Denis Chem Lab Limited was incorporated in 1980 and was converted into a Public Limited Company in 1982.
The Company was registered with Directorate General of Technical Development (DGTD) for manufacturing 4 million bottles of I.V. Fluids and 75 MT of Bulk Drugs per annum and started commercial production for sterile Intravenous (IV) Injectibles in 1984 and also came up with a rights issue during the year In 1995, it ventured into manufacturing of IV Fluids in PP bottles using BFS technology. The Company is engaged in manufacturing of Pharmaceuticals Transfusion Solution in Bottles.
The Company products are manufactured in ultra modern plant using automatic equipments and facilities, which are conforming to GMP specifications as per WHO norms. These products are filled in glass bottles in volume of 100 ml, 250 ml, 500 ml and 1000 ml.

FAQs for the comparison of Concord Biotech Ltd and Denis Chem Lab Ltd

Which company has a larger market capitalization, Concord Biotech Ltd or Denis Chem Lab Ltd?

Market cap of Concord Biotech Ltd is 14,074 Cr while Market cap of Denis Chem Lab Ltd is 99 Cr

What are the key factors driving the stock performance of Concord Biotech Ltd and Denis Chem Lab Ltd?

The stock performance of Concord Biotech Ltd and Denis Chem Lab Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Concord Biotech Ltd and Denis Chem Lab Ltd?

As of June 12, 2026, the Concord Biotech Ltd stock price is INR ₹1345.3. On the other hand, Denis Chem Lab Ltd stock price is INR ₹72.0.

How do dividend payouts of Concord Biotech Ltd and Denis Chem Lab Ltd compare?

To compare the dividend payouts of Concord Biotech Ltd and Denis Chem Lab Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.